Endoscopic treatment for Zenker's diverticulum
Clinical Outcome of Endoscopic Treatment for Zenker's Diverticulum
This study is testing new, less invasive methods to treat Zenker's diverticulum and see if they can help reduce symptoms for people with this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Istituto Clinico Humanitas Academic / other |
| Locations | 1 site (Rozzano) |
| Trial ID | NCT03948438 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and effectiveness of endoscopic techniques, such as flexible endoscopic septum division (FESD) and per-oral endoscopic septotomy (POES), for treating Zenker's diverticulum, a rare condition characterized by an outpouching at the pharyngoesophageal junction. By using minimally invasive methods, the study aims to provide an alternative to traditional surgical approaches. The research will measure the severity of symptoms in patients undergoing these endoscopic procedures.
Who should consider this trial
Good fit: Ideal candidates for this study are patients experiencing symptoms of Zenker's diverticulum who are seeking endoscopic treatment.
Not a fit: Patients who are pregnant or breastfeeding will not benefit from this study due to exclusion criteria.
Why it matters
Potential benefit: If successful, this study could offer a safer and less invasive treatment option for patients suffering from Zenker's diverticulum.
How similar studies have performed: Other studies have shown promising results with similar endoscopic approaches for treating Zenker's diverticulum, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with symptomatic ZD treated by endoscopic procedures Exclusion Criteria: * pregnancy and breastfeeding
Where this trial is running
Rozzano
- Humanitas Research Hospital — Rozzano, Italy (Recruiting)
Study contacts
- Study coordinator: Alessandro Repici, Prof.
- Email: alessandro.repici@hunimed.eu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.